Neos Therapeutics (NEOS) Tops Q4 EPS by 9c

Neos Therapeutics (NASDAQ: NEOS) reported Q4 EPS of ($0.57), $0.09 better than the analyst estimate of ($0.66). Revenue for the quarter came in at $1.7 million, versus $500 thousand reported last year.

For earnings history and earnings-related data on Neos Therapeutics (NEOS) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Grocery Outlet Holding (GO) PT Raised to $12 at TD Cowen
• Sypris Solutions (SYPR) Reports Q2 Loss of $0.14